Therefore, elucidating the mechanism of RAB32 DNA methylation and its role in GBM development may provide a scientific basis for the development of novel therapeutic strategies targeting RAB32 or its associated signaling pathways. The gene discussed is RAB32; the disease is glioblastoma.